The answer first
Pay partners for marketing events, not medical ones. The safest commission structures for a prescription telehealth brand pay a flat amount per paid membership regardless of what is prescribed, or a percentage of revenue from products that need no prescription (supplements, protein, coaching, lab kits). The risky ones pay a percentage of medication revenue, pay more for a more expensive drug or dose, or pay anyone with a role in the clinical decision. That last group is where fee-splitting, patient-brokering and anti-kickback laws live.
This post is the brand side: how to design the program. Our May post on affiliate and creator risk covers creator vetting and review rules, and how creators launch their own prescription brands covers the other side of the table. Nothing here is legal advice; these laws vary by state, and the commission plan should go past a healthcare lawyer before the first payout.
Five models compared
| Model | How it pays | Where it works | Compliance risk |
|---|---|---|---|
| Flat bounty per paid membership | Fixed amount when a referred patient's first payment clears | Any program; simplest to explain | Moderate: still only pays after approval, so structure matters |
| Revenue share on non-Rx products | Percentage of supplement, protein, coaching or test-kit sales | Wellness add-ons, nutrition, maintenance | Low |
| Tiered bounty | Bounty rises with monthly volume of referred memberships | Creators and publishers with steady traffic | Moderate: watch for pressure tactics near tier lines |
| Flat sponsorship | Fixed fee for content, no performance component | Launches, education content, clinician-adjacent partners | Low; weak accountability |
| Percentage of medication revenue | Share of what the patient pays for the drug, often recurring | Common in ecommerce, borrowed into telehealth | High; we would not run it |
The first row needs a frank note. A bounty paid on a cleared first payment only triggers when a clinician has approved treatment, because nobody is charged before approval (or should not be; see the checkout spec). That makes it closer to "pay per prescription" than founders assume. What separates a defensible bounty from a per-prescription payment is structure: the same amount whatever drug or dose is prescribed, paid by the business entity for marketing, never visible to or shared with prescribers, and calibrated to what the marketing is worth rather than to the order value. Some healthcare counsel will still prefer a flat monthly fee at fair market value, especially for California patients.
Why paying per prescription is dangerous
Three bodies of law point the same way.
The federal anti-kickback statute. It makes it a crime to pay anything of value to induce referrals of items or services paid for by a federal health care program. Most cash-pay telehealth sits outside it, until it does not: if any of your patients fill through Medicare (including the GLP-1 Bridge, live since July 1, 2026) or Medicaid, federal program dollars are in the flow. The HHS Office of Inspector General's Special Fraud Alert of July 20, 2022 lists, among its suspect characteristics, telemedicine companies paying practitioners per order or prescription, on the reasoning that pay which rises with the number of orders pushes clinicians toward ordering (Goodwin summary of the alert). That alert is about clinicians, but a commission plan that rewards affiliates for prescriptions written creates the same incentive one step upstream.
State all-payor laws. Florida's Patient Brokering Act (Fla. Stat. § 817.505) has long been read to extend kickback logic to every payor, cash included, and it reaches "any person," not only providers (Foley & Lardner). Violations are felonies. A Florida affiliate paid a percentage of prescription revenue for Florida patients is exactly the arrangement the statute addresses.
State fee-splitting rules. California Business and Professions Code § 650 prohibits compensation for patient referrals. California health lawyers commonly advise that percentage or per-patient payments to marketers and lead generators are fee-splitting risk and recommend flat fees at fair market value instead (Bay Legal). The professional corporation that employs your clinicians cannot split its fees with your affiliates, and if your MSO's management fee is a percentage of the PC's revenue, an affiliate share layered on top of it deserves a hard look. The MSO and friendly-PC explainer covers the structure.
Where we are unsure: we have not found enforcement against a DTC cash-pay brand specifically for affiliate commissions. The statutes and the OIG's reasoning are clear enough that we would not want to be the first.
Disclosure: what an affiliate post has to show
The FTC's Endorsement Guides, revised and published July 26, 2023 (16 CFR Part 255), require disclosure of a material connection between endorser and advertiser when "a significant minority of the audience" would not expect it. A commission is a material connection. So is free treatment. The Guides also make the advertiser liable for deceptive endorsements even when the endorser is not (Manatt), which is why the brand has to police partner content rather than trust it.
Our working rules for partners:
- Disclosure in the post itself, before the "more" fold, in plain words ("I earn a commission if you sign up"). A tag buried among twenty hashtags fails.
- Spoken disclosure in video, early, not only in the caption.
- Patients who refer friends for a credit disclose the credit too.
- No reviews in exchange for commissions or discounts conditioned on sentiment; the FTC's Consumer Reviews and Testimonials Rule (effective October 21, 2024) carries civil penalties.
The claims library
Give partners copy they can use and a list they cannot. The second column is where the FDA's March 3, 2026 letters to 30 telehealth companies landed, along with the larger wave in September 2025.
| Partners may say | Partners may not say |
|---|---|
| "A licensed clinician reviews your health history and decides if treatment is right for you." | "Get approved in minutes" or "everyone qualifies" |
| "Not everyone is eligible." | Any weight-loss figure that is not the brand's approved, sourced claim |
| "Pricing is shown before you pay." | "Same as Wegovy" or "generic Zepbound" about a compounded product |
| "I used the program and here is my experience" (if true and disclosed) | "FDA approved" about anything compounded |
| The approved headline, offer and disclaimer, unedited | Side-effect reassurance ("no side effects", "totally safe") |
Version the library, date it, and require partners to pull from the current version. When a price or a product changes, old creative becomes a misrepresentation overnight. Running GLP-1 ads in 2026 has the paid-media version of the same rules.
Attribution and fraud
Health affiliate fraud is mostly ordinary affiliate fraud with a higher price per event. Self-referral (partners signing up themselves or family for a bounty), coupon-site leakage (a partner's code posted to a deal site and claimed against organic traffic), duplicate accounts, and partners bidding on your brand name in paid search are the usual four. Controls that work:
- Holdback until the first refill clears. Paying the bounty 30 to 45 days after the first charge removes most refund and chargeback fraud, and it aligns partners with patients who stay.
- Clawback on refund or dispute inside the holdback window, written into the partner terms.
- Self-referral checks on payment method, address and device against the partner's own account.
- Brand-term bidding banned in the partner agreement, and monitored.
- Attribution tied to the paid order, not the click. A partner whose traffic converts to intake starts but never to paid memberships is sending you curiosity, and your clinicians are paying for it in review time.
Where Turbopills fits
Turbopills includes an Affiliate Program wired into the same system as intake, billing and the patient record: tracking links on your own domain, referrals attributed to intake submissions and billing events, a commission engine with per-product overrides, holdbacks, self-referral detection, payouts and tax forms, and a branded partner portal with a copy library. Because commissions are calculated from billing events, you can pay on a cleared membership and exclude medication revenue from rev share without a spreadsheet.
The engine is configurable, which cuts both ways: it will calculate whatever commission you set up. Which event you pay on, how much, and what partners may say are your decisions with your counsel, and we would rather you made them before you recruit. We are in private beta; ask to see a referral move from link to payout in the demo.
FAQ
Can a telehealth company pay affiliates per prescription? It is the highest-risk model. Federal anti-kickback law applies wherever federal program dollars are involved, and states like Florida apply patient-brokering rules to all payors. Pay per paid membership at a flat amount, independent of drug or dose, and have counsel review it.
Is revenue share allowed for telehealth affiliates? On non-prescription products (supplements, protein, coaching, test kits), revenue share is the low-risk model. A percentage of medication revenue is the model we would avoid.
Do telehealth affiliates need to disclose commissions? Yes. Under the FTC's Endorsement Guides a commission is a material connection that must be disclosed clearly in the post, and the brand is liable for deceptive endorsements by its partners.
Can patients earn referral credits? Commonly done, with the same care: a flat credit, not tied to what the friend is prescribed, disclosed when the patient posts about it, and reviewed by counsel for states with all-payor laws.